Format

Send to

Choose Destination
J Clin Oncol. 2007 Oct 1;25(28):4506-7; author reply 4508.

Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value?

PMID:
17906218
DOI:
10.1200/JCO.2007.13.0401
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center